[1]
Z. SHPRAKH, “SOMATOSTATIN ANALOGUES FOR THE TREATMENT OF NEUROENDOCRINE TUMOURS. DOSAGE FORMS AND ROUTES OF ADMINISTRATION (REVIEW)”, Int J App Pharm, vol. 12, no. 2, pp. 6-11, Jan. 2020.